Stay updated on Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Sign up to get notified when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.

Latest updates to the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.0 replaces the previous v3.4.3 on the page.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded the JAMA Intern Med article on COVID-19 risk factors to Publications and removed the Erratum entry for that article.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check40 days agoChange DetectedPublication citation updated to include an erratum note for the JAMA Intern Med article.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated to v3.4.2; the previous v3.4.1 notice and the government funding lapse notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a government funding notice about potential delays and the NIH Clinical Center’s status, and updated the page version from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camostat+Artemisia Annua vs Placebo in COVID-19 Outpatients Clinical Trial page.